We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Study of Lanreotide to Treat Polycystic Kidney Disease (DIPAK1)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01616927
Recruitment Status : Active, not recruiting
First Posted : June 12, 2012
Last Update Posted : May 23, 2017
Information provided by (Responsible Party):